CLINICAL_TRIALS
ClinicalTrials.gov record update
A Feasibility Study Evaluating Haploidentical Allogeneic Transplantation Using the CliniMACS System in Patients With Advanced Hematologic Malignancies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00185679
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:35:44.531801+00:00
- Published At
- 2015-03-09T00:00:00+00:00
- Record Updated At
- 2015-03-09
- Results Posted At
- 2015-03-09
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors", "Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase", "Myelodysplastic Syndrome (MDS) - High and Intermediate Risk", "Non-Hodgkin\u0027s Lymphoma (NHL)", "Chronic Lymphocytic Leukemia (CLL) - Refractory"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-03-09"- protocolSection.identificationModule.nctId
"NCT00185679"- protocolSection.identificationModule.officialTitle
"A Feasibility Study Evaluating Haploidentical Allogeneic Transplantation Using the CliniMACS System in Patients With Advanced Hematologic Malignancies"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-03-09"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.